α<sub>2</sub>-macroglobulin co-administered <i>in vivo</i> promotes antigen delivery and presentation
- 1 Department of Pathology, Duke University Medical Center, Durham, USA
- 2 Department of Pathology, Duke University Medical Center, Durham, USA
- 3 Department of Pathology, Duke University Medical Center, Durham, USA
- 4 Department of Pathology, Duke University Medical Center, Durham, USA
Abstract
Administered in vivo, covalent receptor-recognized α 2 -macroglobulin (α 2 M * )-antigen complexes enhance humoral and cell-mediated immunity. We hypothesized that in vivo α 2 M * -encapsulation could be promoted in the setting of vaccines that co-deliver α 2 M * with unbound antigen, thereby eliminating the need to prepare complexes in vitro. Mice immunized intradermally with co-delivered α 2 M * and OVA demonstrated antigen-specific immune responses, including anti-tumor responses, similar to those elicited by conjugated α 2 M * -OVA complexes. Enhanced immunity appears to result from in vivo α 2 M * -encapsulation of antigen. This finding represents a significant advancement in the development of α 2 M * as an antigen delivery vehicle capable of enhancing the presentation of subunit vaccines.
- Chu, C.T., Oury, T.D., Enghild, J.J. and Pizzo, S.V. (1994) Adjuvant-free in vivo targeting. Antigen delivery by alpha 2-macroglobulin enhances antibody formation. Journal of Immunology, 152, 1538-1545.
- Chu, C.T. and Pizzo, S.V. (1993) Receptor-mediated antigen delivery into macrophages. Complexing antigen to alpha2-macroglobulin enhances presentation to T cells. Journal of Immunology, 150, 48-58.
- Cianciolo, G.J., Enghild, J.J. and Pizzo, S.V. (2001) Co-valent complexes of antigen and alpha2-macroglobulin: Evidence for dramatically-increased immunogenicity. Vaccine, 20, 554-562. doi:10.1016/S0264-410X(01)00361-9
- Liao, H.X., Cianciolo, G.J., Staats, H.F., Scearce, R.M., Lapple, D.M., Stauffer, S.H., Thomasch, J.R., Pizzo, S.V., Montefiori, D.C., Hagen, M., Eldridge, J. and Haynes, B.F. (2002) Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF. Vaccine, 20, 2396-2403. doi:10.1016/S0264-410X(02)00090-7
- Binder, R.J., Karimeddini, D. and Srivastava, P.K. (2001) Adjuvanticity of alpha2-macroglobulin, an independent ligand for the heat shock protein receptor CD91. Journal of Immunology, 166, 4968-4972.
- Binder, R.J., Kumar, S.K. and Srivastava, P.K. (2002) Naturally formed or artificially reconstituted non-covalent alpha2-macroglobulin-peptide complexes elicit CD91-dependent cellular immunity. Cancer Immunity, 2, 16.
- Bowers, E.V., Horvath, J.J., Bond, J.E., Cianciolo, G.J. and Pizzo, S.V. (2009) Antigen delivery by alpha(2)- macroglobulin enhances the cytotoxic T lymphocyte response. Journal of Leukocyte Biology, 86, 1259-1268. doi:10.1189/jlb.1008653
- Gron, H. and Pizzo, S.V. (1998) Nonproteolytic incorporation of protein ligands into human alpha2-macroglobulin: Implications for the binding mechanism of alpha 2-macroglobulin. Biochemistry, 37, 6009-6014.
- Adlakha, C.L., Hart, J.P. and Pizzo, S.V. (2001) Kinetics of nonproteolytic incorporation of a protein ligand into thermally activated alpha2-macroglobulin: Evidence for a novel nascent state. The Journal of Biological Chemistry, 276, 41547-41552. doi:10.1074/jbc.M106357200
- Bhattacharjee, G., Gron, H. and Pizzo, S.V. (1999) Incorporation of non-proteolytic proteins by murine alpha2- macroglobulin. Biochimica et Biophysica Acta (BBA) —Protein Structure and Molecular Enzymology, 1432, 49-56. doi:10.1016/S0167-4838(99)00072-2
- Gron, H., Thogersen, I.B., Enghild, J.J. and Pizzo, S.V. (1996) Structural and functional analysis of the spontaneous reformation of the thiol ester bond in human alpha 2-macroglobulin, rat alpha1-inhibitor-3 and chemically modified derivatives. Biochemical Journal, 318, 539-545.